Category: Company News

Cefaly Can Help Migraineurs Miss Fewer Days of Work

Cefaly, the first FDA-approved external trigeminal nerve stimulation device for the prevention of frequent episodic migraine attacks, is able to help some migraine patients miss fewer days of work, feel less groggy in the workplace, and enjoy more social activities.

Posted in Company News Tagged with: , , , , , , ,

Cefaly Introduces Option to Buy Now and Pay Later through PayPal Credit

CEFALY Technology announced today that Cefaly®, the first FDA-approved external trigeminal nerve stimulation device for the prevention of frequent episodic migraine attacks, will become available for purchase via PayPal Credit starting this June, in a nod toward Migraine Awareness Month.

Posted in Company News Tagged with: , , , , , , , , , , , , , ,

Study Finds Migraine Device Cefaly an Effective Treatment for Refractory Migraine

A new clinical trial reveals that Cefaly®, the first FDA-approved external trigeminal nerve stimulation device for the prevention of frequent episodic migraines, has been used successfully on migraine patients who do not respond to usual oral migraine medication (refractory migraine).

Posted in Company News Tagged with: , , , , , , , , , , ,

Migraine Medical Device Cefaly is Successful in a Recent Trial on Chronic Migraine

A newly published clinical trial reveals that Cefaly®, the first FDA-approved external trigeminal nerve stimulation device for the prevention of frequent episodic migraine attacks, has been used successfully on patients suffering from chronic migraine. The results, published in Neurological Sciences,

Posted in Company News Tagged with: , , , , , ,

Meet the New Cefaly II

The Cefaly team is proud to present to you the new Cefaly device, available exclusively in the United States! Meet the Cefaly II ! The popular and innovative FDA-approved medical treatment first gained popularity for Cefaly I, with its unique headband-like

Posted in Company News Tagged with: , , ,